Gene Sequencing Market Growth Analysis, Market Dynamics, Key...

Gene Sequencing Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032

Postado 2025-07-04 09:17:22

According to a new market analysis, the global gene sequencing market was valued at USD 21.67 billion in 2024 and is projected to reach USD 74.61 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 19.4% during the forecast period (2025–2032). This explosive growth is driven by advancements in next-generation sequencing (NGS) technologies, increasing prevalence of genetic disorders, and expanding applications in precision medicine.

Download FREE Sample Report:
Gene Sequencing Market - View in Detailed Research Report

What is Gene Sequencing?

Gene sequencing is a laboratory technique that determines the exact order of nucleotides within DNA molecules. This process enables comprehensive analysis of genetic information, providing critical insights into biological functions, disease mechanisms, and hereditary patterns. Modern sequencing technologies, particularly next-generation sequencing (NGS), have revolutionized the field by enabling high-throughput, cost-effective genomic analysis at unprecedented scales.

The NGS segment currently dominates with 82% market share, while emerging technologies like nanopore sequencing and single-molecule real-time (SMRT) sequencing are pushing boundaries further. A human genome can now be sequenced for under $600—a dramatic reduction from millions of dollars just two decades ago.

Key Market Drivers

1. Technological Advancements Accelerating Adoption

The field has seen remarkable progress in sequencing speed, accuracy, and cost-efficiency. Illumina's NovaSeq X series, for example, can sequence 20,000 genomes per year at under $200 per genome. These improvements are making genomic analysis accessible to broader medical and research applications.

2. Rising Prevalence of Genetic Disorders

With approximately 6-8% of the global population affected by rare genetic disorders (70-80 million people according to WHO estimates), demand for sequencing services continues to grow. In oncology, tumor genome sequencing has become standard practice, while applications in rare disease diagnostics are expanding rapidly.

3. Integration with AI and Bioinformatics

The combination of sequencing with artificial intelligence represents a major breakthrough. As seen with Valted Seq's AI-powered SCADE platform (launched April 2025), machine learning can analyze complex genomic data with >96% accuracy, dramatically accelerating interpretation workflows.

Market Challenges

Despite strong growth prospects, the industry faces several hurdles:

High infrastructure costs: Establishing a sequencing lab requires millions in capital expenditure for instruments and computing resources
Data privacy concerns: Handling sensitive genetic information presents regulatory and ethical challenges across jurisdictions
Skill shortages: The rapid market expansion has created critical shortages of qualified bioinformaticians and genomic specialists

Additionally, reimbursement uncertainties for genomic tests and the complexities of managing massive datasets (a single genome produces ~200GB of raw data) present ongoing operational challenges.

Opportunities Ahead

The Asia-Pacific region presents one of the most promising growth areas, with projected CAGRs exceeding 25% in countries like China and India. Meanwhile, new clinical applications are emerging across multiple therapeutic areas:

Non-invasive prenatal testing (NIPT) expansion
Liquid biopsy applications for cancer monitoring
Microbiome analysis and pharmacogenomics

Technological convergence with CRISPR gene editing and single-cell analysis is creating new research frontiers. Strategic collaborations between sequencing companies and tech firms—like Eli Lilly's $1.3 billion acquisition of Verve Therapeutics (June 2025)—highlight the sector's innovation potential.

Regional Market Insights

North America dominates with 33% market share, driven by advanced infrastructure, substantial R&D investments, and initiatives like the All of Us Research Program.
Europe follows closely with 32% share, characterized by strong academic collaborations and unified regulatory frameworks including GDPR for genomic data.
Asia-Pacific is the fastest-growing region, with China accounting for over half of regional revenue through government-backed initiatives like the China National GeneBank.
Latin America and Middle East/Africa represent emerging markets where investment in genomic medicine is accelerating, though infrastructure gaps remain.

Competitive Landscape

The market features a semi-consolidated structure with several key players:

Illumina (18% market share) leads with its comprehensive NGS platforms
Thermo Fisher Scientific and Eurofins Scientific (combined 13% share) maintain strong positions through strategic acquisitions
BGI Genomics and Oxford Nanopore represent disruptive forces with cost-effective and portable sequencing solutions

Recent product launches like Ultima Genomics' UG 100 Solaris platform (February 2025) demonstrate the industry's focus on improving throughput while reducing costs by ~20%.

Market Segmentation

By Technology:

Next-generation sequencing (NGS)
Third and fourth generation sequencing
First-generation sequencing
Others

By Application:

Academic research
Drug Discovery & Development
Agricultural & Animal Genomics
Forensics
Reproductive Health (NIPT, carrier screening)
Personalized Medicine
Others

By End User:

Hospitals & Clinics
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Diagnostic Laboratories
Forensic Laboratories

By Region:

North America, Europe, Asia, Latin America, Middle East & Africa

Report Scope & Offerings

This comprehensive report provides:

2025–2032 market size & forecasts for global and regional markets.
Competitive intelligence on 14+ key players including Illumina, Thermo Fisher, BGI Genomics, and Oxford Nanopore.
SWOT, value chain, and trend analysis.
Segmentation insights by technology, application, end-user, and region.

Download FREE Sample Report:
Gene Sequencing Market - View in Detailed Research Report

Get Full Report Here: https://www.intelmarketresearch.com/reports/968/gene-sequencing-2025-2032-394

Visit more reports :

About Intel Market Research

Intel Market Research delivers actionable insights in technology and infrastructure markets. Our data-driven analysis leverages:

Real-time infrastructure monitoring
Techno-economic feasibility studies

Competitive intelligence across 100+ countries
Trusted by Fortune 500 firms, we empower strategic decisions with precision.

International: +1(332) 2424 294 | Asia: +91 9169164321

Website: https://www.intelmarketresearch.com

Follow us on LinkedIn: https://www.linkedin.com/company/intel-market-research